These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33541674)
1. 5-HT interaction with other neurotransmitters: An overview. De Deurwaerdere P; Di Giovanni G Prog Brain Res; 2021; 259():1-5. PubMed ID: 33541674 [TBL] [Abstract][Full Text] [Related]
2. Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence. De Deurwaerdère P; Chagraoui A; Di Giovanni G Prog Brain Res; 2021; 261():161-264. PubMed ID: 33785130 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence. Mendiguren A; Aostri E; Pineda J Adv Exp Med Biol; 2021; 1297():111-132. PubMed ID: 33537940 [TBL] [Abstract][Full Text] [Related]
4. Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects. Mendiguren A; Aostri E; Pineda J Life Sci; 2018 Jan; 192():115-127. PubMed ID: 29169951 [TBL] [Abstract][Full Text] [Related]
5. Brain noradrenaline and the mechanisms of action of antidepressant drugs. Svensson TH Acta Psychiatr Scand Suppl; 2000; 402():18-27. PubMed ID: 10901155 [TBL] [Abstract][Full Text] [Related]
6. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Jobe PC Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464 [TBL] [Abstract][Full Text] [Related]
7. Monoamine neurocircuitry in depression and strategies for new treatments. Hamon M; Blier P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950 [TBL] [Abstract][Full Text] [Related]
8. Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. El Mansari M; Guiard BP; Chernoloz O; Ghanbari R; Katz N; Blier P CNS Neurosci Ther; 2010 Jun; 16(3):e1-17. PubMed ID: 20406250 [TBL] [Abstract][Full Text] [Related]
9. Role of central serotonin and noradrenaline interactions in the antidepressants' action: Electrophysiological and neurochemical evidence. Delcourte S; Etievant A; Haddjeri N Prog Brain Res; 2021; 259():7-81. PubMed ID: 33541681 [TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid-serotonin systems interaction in health and disease. Colangeli R; Teskey GC; Di Giovanni G Prog Brain Res; 2021; 259():83-134. PubMed ID: 33541682 [TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory role of neurotransmitters. Qiu Y; Peng Y; Wang J Adv Neuroimmunol; 1996; 6(3):223-31. PubMed ID: 8968422 [TBL] [Abstract][Full Text] [Related]
15. Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina. Gu L; Liu YJ; Wang YB; Yi LT J Ethnopharmacol; 2012 Feb; 139(3):780-7. PubMed ID: 22197914 [TBL] [Abstract][Full Text] [Related]
16. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Shiah IS; Yatham LN Bipolar Disord; 2000 Jun; 2(2):77-92. PubMed ID: 11252655 [TBL] [Abstract][Full Text] [Related]
17. Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease. Werner FM; Covenas R Curr Pharm Des; 2016; 22(14):2064-71. PubMed ID: 26818863 [TBL] [Abstract][Full Text] [Related]
19. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
20. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Millan MJ; Brocco M; Gobert A; Dekeyne A Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]